Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
samedi, octobre 17
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
RxSight Inc
RXST
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$4.51
-0.16
-3.43%
Dern. MÀJ: Oct 16, 4:00 PM
$4.51
-0.16
-3.43%
Get Report
Aperçu
Actualités
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Comparer
Options
Rapport sur les stocks
Privacy Manager
RxSight Financials
RxSight (RXST) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
RxSight Q2 Adj. EPS $(0.11) Beats $(0.33) Estimate, Sales $33.741M Beat $32.547M Estimate
Benzinga Newsdesk
Stock Market Today: Dow Jones Futures Gain, S&P 500, Nasdaq 100 Slips As SpaceX Debuts On The Exchange—Rivian, Micron In Focus (UPDATED)
U.S. stock futures were mixed on Tuesday, as the Dow Jones index rose while the Nasdaq 100 and S&P 500 indices fell.
Rishabh Mishra
PRO
RxSight Sees Q2 Sales $32.000M-$34.000M vs $32.077M Est
RxSight (NASDAQ:RXST) sees Q2 sales of $32.000 million-$34.000 million vs $32.077 million analyst estimate.
Benzinga Newsdesk
PRO
RxSight Raises FY2026 Sales Guidance from $120.000M-$135.000M to $140.000M-$160.000M vs $129.250M Est
RxSight (NASDAQ:RXST) raises FY2026 sales outlook from $120.000 million-$135.000 million to $140.000 million-$160.000 million vs $129.250 million estimate.
Benzinga Newsdesk
PRO
RxSight Sees Q2 Revenue Of $32M-$34M; Sees FY2026 Revenue Of $140M-$160M
RxSight, Inc. (NASDAQ:RXST) today announced select preliminary financial results for the second quarter of 2026 and updates to its standalone product pipeline, following the announcement of the company’s strategic
Benzinga Newsdesk
Earnings Scheduled For May 6, 2026
Benzinga Insights
